COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,796 Articles (22,527 medRxiv, 8,269 bioRxiv)

Most recent first Previous |  Page 2418: Articles 24171-24180  | Next

Training and reployment of non-specialists is an effective solution for the shortage of health care workers in the COVID-19 pandemic
Kuang, M., Wu, J., Luo, Y., Xiao, H., Liang, R., Hu, W., Cheng, S., Zhou, Q., Peng, S., Cheng, K., Xiao, H.
10.1101/2020.07.17.20156117 — Posted: 2020-07-17
HIGH VERSUS STANDARD DOSES OF CORTICOSTEROIDS IN COVID-19 PATIENTS WITH AN ACUTE RESPIRATORY DISTRESS SYNDROME: a controlled observational comparative study.
Monreal, E., Sainz de la Maza, S., Natera-Villalba, E., Beltran-Corbellini, A., Rodriguez-Jorge, F., Fernandez-Velasco, J. I., Walo-Delgado, P., Muriel, A., Zamora, J., Alonso-Canovas, A., Fortun, J., Manzano, L., Montero-Errasquin, B., Costa-Frossard, L., Masjuan, J., Villar, L. M.
10.1101/2020.07.17.20156315 — Posted: 2020-07-17
Simulations support the interaction of the SARS-CoV-2 spike protein with nicotinic acetylcholine receptors and suggest subtype specificity
Oliveira, A. S., Ibarra, A. A., Bermudez, I., Casalino, L., Gaieb, Z., Shoemark, D. K., Gallagher, T., Sessions, R. B., Amaro, R. E., Mulholland, A. J.
10.1101/2020.07.16.206680 — Posted: 2020-07-17 Discussion: Onsite
Identification of SARS-CoV2-mediated suppression of NRF2 signaling reveals a potent antiviral and anti-inflammatory activity of 4-octyl-itaconate and dimethyl fumarate
Olagnier, D., Farahani, E., Thyrsted, J., Cadanet, J. B., Herengt, A., Idorn, M., Hait, A., Hernaez, B., Knudsen, A., Iversen, M. B., Schilling, M., Jorgensen, S. E., Thomsen, M., Reinert, L., Lappe, M., Hoang, H.-D., Gilchrist, V. H., Hansen, A.-L., Ottosen, R., Gunderstofte, C., Moller, C., van der Horst, D., Peri, S., Balachandran, S., Huang, J., Jakobsen, M., Svenningsen, E. B., Poulsen, T. B., Bartsch, L., Thielke, A. L., Luo, Y., Alain, T., Rehwinkel, J., Alcami, A., Hiscott, J., Mogensen, T., Paludan, S. R., Holm, C. K.
10.1101/2020.07.16.206458 — Posted: 2020-07-17 Discussion: Offsite
COVID-19 patients upregulate toll-like receptor 4-mediated inflammatory signaling that mimics bacterial sepsis
Sohn, K. M., Lee, S.-G., Kim, H. J., Cheon, S., Jeong, H., Lee, J., Kim, I. S., Silwal, P., Kim, Y. J., Park, C., Kim, Y.-S., Jo, E.-K.
10.1101/2020.07.17.207878 — Posted: 2020-07-17 Discussion: Onsite | Offsite
Systematic modeling of SARS-CoV-2 protein structures
O'Donoghue, S. I., Schafferhans, A., Sikta, N., Stolte, C., Kaur, S., Ho, B., Anderson, S., Procter, J. B., Adcock, M., Dallago, C., Bordin, N., Rost, B.
10.1101/2020.07.16.207308 — Posted: 2020-07-17
Development of a simple in vitro assay to identify and evaluate nucleotide analogs against SARS-CoV-2 RNA-dependent RNA polymerase
Lu, G., Zhang, X., Zheng, W., Sun, J., Hua, L., Xu, L., Chu, X.-j., Ding, S., Xiong, W.
10.1101/2020.07.16.205799 — Posted: 2020-07-17
Confirmed central olfactory system lesions on brain MRI in COVID-19 patients with anosmia: a case-series
Girardeau, Y., GALLOIS, Y., DE BONNECAZE, G., ESCUDE, B., LAFONT, C., CHATELLIER, G., MARX, M.
10.1101/2020.07.08.20148692 — Posted: 2020-07-17
Impact of climatic, demographic and disease control factors on the transmission dynamics of COVID-19 in large cities worldwide
Metelmann, S., Pattni, K., Brierley, L., Cavalerie, L., Caminade, C., Blagrove, M. S., Turner, J., Sharkey, K. J., Baylis, M.
10.1101/2020.07.17.20155226 — Posted: 2020-07-17 Discussion: Onsite
Single-Cell Omics Reveals Dyssynchrony of the Innate and Adaptive Immune System in Progressive COVID-19
Unterman, A., Sumida, T. S., Nouri, N., Yan, X., Zhao, A. Y., Gasque, V., Schupp, J. C., Asashima, H., Liu, Y., Cosme, C., Deng, W., Chen, M., Brickman Raredon, M. S., Hoehn, K., Wang, G., Wang, Z., Deiuliis, G., Ravindra, N. G., Li, N., Castaldi, C., Wong, P., Fournier, J., Bermejo, S., Sharma, L., Casanovas-Massana, A., Vogels, C. B. F., Wyllie, A. L., Grubaugh, N. D., Melillo, A., Meng, H., Minasyan, M., The Yale IMPACT research team, , Niklason, L. E., Ko, A. I., Montgomery, R. R., Farhadian, S. F., Iwasaki, A., Shaw, A. C., van Dijk, D., Zhao, H., Kleinstein, S. H., Hafler, D. A., Kaminski, N., Dela Cruz, C. S.
10.1101/2020.07.16.20153437 — Posted: 2020-07-17 Discussion: Onsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).